Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-25-096729
Filing Date
2025-04-25
Accepted
2025-04-25 16:05:10
Documents
9

Document Format Files

Seq Description Document Type Size
1 DEFA14A d838751ddefa14a.htm DEFA14A 22689
2 GRAPHIC g838751g02x01.jpg GRAPHIC 11723
3 GRAPHIC g838751g02x03.jpg GRAPHIC 3796
4 GRAPHIC g838751g02x04.jpg GRAPHIC 3258
5 GRAPHIC g838751g02x05.jpg GRAPHIC 3841
6 GRAPHIC g838751g04x01.jpg GRAPHIC 25966
7 GRAPHIC g838751g04x02.jpg GRAPHIC 63332
8 GRAPHIC g838751g04x04.jpg GRAPHIC 5312
9 GRAPHIC g838751sp3.jpg GRAPHIC 4903
  Complete submission text file 0001193125-25-096729.txt   193102
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Filer) CIK: 0001439222 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36014 | Film No.: 25873785
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)